Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
5741.T Stock Summary
Top 10 Correlated ETFs
5741.T
In the News
5741.T Financial details
Company Rating
Buy
Market Cap
219.64B
Income
4.17B
Revenue
894.84B
Book val./share
5400.89
Cash/share
930.19
Dividend
125
Dividend %
3.31%
Employees
9.51K
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-30.58
Forward P/E
-
PEG
3.52
P/S
0.2
P/B
0.69
P/C
4.93
P/FCF
28.34
Quick Ratio
0.54
Current Ratio
1.19
Debt / Equity
1.38
LT Debt / Equity
0.68
-
-
EPS (TTM)
86.42
EPS next Y
-
EPS next Q
-
EPS this Y
-85.33%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
33.35%
Revenue last 5Y
7.8%
Revenue Q/Q
0.67%
EPS Q/Q
38.41%
-
-
-
-
SMA20
6.71%
SMA50
11.78%
SMA100
44.69%
Inst Own
-
Inst Trans
-
ROA
-1%
ROE
-2%
ROC
0.02%
Gross Margin
9%
Oper. Margin
1%
Profit Margin
-1%
Payout
-69%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2529.0-4595.0
52W High
-0.11%
52W Low
+81.49%
RSI
59
Rel Volume
1.22
Avg Volume
129.92K
Volume
159.1K
Perf Week
1.21%
Perf Month
10.2%
Perf Quarter
56.92%
Perf Half Y
51.24%
-
-
-
-
Beta
1.193
-
-
Volatility
93.31%, 179%
Prev Close
-2.34%
Price
4590
Change
0%
5741.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 13.71K | 12.75K | 11.81K | 16.23K | 19.97K | |
Net income per share | 23.13 | 42.25 | -67.78 | 664.69 | 97.53 | |
Operating cash flow per share | 220.8 | 1.2K | 800.83 | 161.72 | 1.09K | |
Free cash flow per share | -753.33 | 98.44 | 306.99 | -272.33 | 546 | |
Cash per share | 159.21 | 263.98 | 264.59 | -74.46 | 40.69 | |
Book value per share | 3.96K | 3.91K | 3.8K | 4.73K | 5.14K | |
Tangible book value per share | 3.11K | 3.16K | 3.15K | 4.26K | 4.76K | |
Share holders equity per share | 3.96K | 3.91K | 3.8K | 4.73K | 5.14K | |
Interest debt per share | 8.28K | 7.61K | 7.63K | 7.65K | 7.71K | |
Market cap | 102.31B | 74.91B | 128.67B | 112.7B | 127.06B | |
Enterprise value | 468.37B | 406.18B | 462.16B | 461B | 468.93B | |
P/E ratio | 91.68 | 36.76 | -39.36 | 3.52 | 27.02 | |
Price to sales ratio | 0.15 | 0.12 | 0.23 | 0.14 | 0.13 | |
POCF ratio | 9.61 | 1.29 | 3.33 | 14.45 | 2.42 | |
PFCF ratio | -2.82 | 15.78 | 8.69 | -8.58 | 4.83 | |
P/B Ratio | 0.54 | 0.4 | 0.7 | 0.49 | 0.51 | |
PTB ratio | 0.54 | 0.4 | 0.7 | 0.49 | 0.51 | |
EV to sales | 0.71 | 0.66 | 0.81 | 0.59 | 0.49 | |
Enterprise value over EBITDA | 10.95 | 9.8 | 10.11 | 4.85 | 8.39 | |
EV to operating cash flow | 43.97 | 6.99 | 11.97 | 59.11 | 8.92 | |
EV to free cash flow | -12.89 | 85.55 | 31.21 | -35.1 | 17.81 | |
Earnings yield | 0.01 | 0.03 | -0.03 | 0.28 | 0.04 | |
Free cash flow yield | -0.36 | 0.06 | 0.12 | -0.12 | 0.21 | |
Debt to equity | 2.06 | 1.91 | 1.98 | 1.59 | 1.47 | |
Debt to assets | 0.49 | 0.48 | 0.49 | 0.44 | 0.42 | |
Net debt to EBITDA | 8.56 | 7.99 | 7.3 | 3.67 | 6.11 | |
Current ratio | 1.27 | 1.09 | 1.17 | 1.23 | 1.21 | |
Interest coverage | 2.21 | 1.46 | 1.75 | 9.4 | 2.24 | |
Income quality | 1.06 | -35.83 | 11.12 | 0.16 | 7.34 | |
Dividend Yield | 0.01 | 0.04 | 0.01 | 0 | 0.03 | |
Payout ratio | 1.3 | 1.42 | -0.3 | 0 | 0.87 | |
Sales general and administrative to revenue | 0.06 | 0.06 | 0.07 | 0.05 | 0.05 | |
Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Intangibles to total assets | 0.07 | 0.07 | 0.06 | 0.05 | 0.05 | |
Capex to operating cash flow | -4.41 | -0.92 | -0.62 | -2.68 | -0.5 | |
Capex to revenue | -0.07 | -0.09 | -0.04 | -0.03 | -0.03 | |
Capex to depreciation | -1.53 | -1.71 | -0.71 | -0.61 | -0.7 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.44K | 1.93K | 2.41K | 8.41K | 3.36K | |
ROIC | 0 | -0.03 | -0.01 | 0.07 | 0.02 | |
Return on tangible assets | 0 | 0 | 0 | 0.04 | 0.01 | |
Graham Net | -8.43K | -8.16K | -7.63K | -7.81K | -7.95K | |
Working capital | 75.02B | 24.49B | 43.35B | 72.48B | 71.27B | |
Tangible asset value | 150.21B | 152.6B | 151.93B | 205.59B | 229.52B | |
Net current asset value | -252.73B | -261.15B | -242.01B | -186.52B | -180.97B | |
Invested capital | 2.06 | 1.91 | 1.98 | 1.59 | 1.47 | |
Average receivables | 140.2B | 123.07B | 110.44B | 121.34B | 123.87B | |
Average payables | 121.94B | 109.28B | 98.56B | 109.82B | 118.32B | |
Average inventory | 150.11B | 145.51B | 133.81B | 182.03B | 227.95B | |
Days sales outstanding | 80.15 | 59.88 | 76.85 | 57.21 | 47.39 | |
Days payables outstanding | 75.94 | 63.84 | 73.18 | 66.25 | 49.87 | |
Days of inventory on hand | 96.13 | 90.36 | 95.34 | 129.86 | 94.39 | |
Receivables turnover | 4.55 | 6.1 | 4.75 | 6.38 | 7.7 | |
Payables turnover | 4.81 | 5.72 | 4.99 | 5.51 | 7.32 | |
Inventory turnover | 3.8 | 4.04 | 3.83 | 2.81 | 3.87 | |
ROE | 0.01 | 0.01 | -0.02 | 0.14 | 0.02 | |
Capex per share | -974.13 | -1.11K | -493.83 | -434.06 | -544.52 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 4.95K | 4.86K | 4.38K | 4.64K | 4.67K | |
Net income per share | -163.47 | -54.48 | 60.7 | 33.64 | 46.56 | |
Operating cash flow per share | 325.37 | 681.57 | -47.53 | 556.8 | 439.13 | |
Free cash flow per share | 168.08 | 578.04 | -238.07 | 371.46 | 296.25 | |
Cash per share | 549.61 | 451.27 | 768.32 | 878.91 | 930.19 | |
Book value per share | 5.25K | 5.14K | 5.36K | 5.51K | 5.4K | |
Tangible book value per share | 4.84K | 4.76K | 4.02K | 4.16K | 4.98K | |
Share holders equity per share | 5.25K | 5.14K | 5.36K | 5.51K | 5.4K | |
Interest debt per share | 7.72K | 7.63K | 7.91K | 7.76K | 7.58K | |
Market cap | 106.96B | 127.06B | 131.11B | 151.41B | 185.65B | |
Enterprise value | 452.19B | 468.93B | 486.02B | 489.64B | 509.95B | |
P/E ratio | -3.39 | -12.09 | 11.2 | 23.34 | 20.67 | |
Price to sales ratio | 0.45 | 0.54 | 0.62 | 0.68 | 0.82 | |
POCF ratio | 6.82 | 3.87 | -57.2 | 5.64 | 8.77 | |
PFCF ratio | 13.2 | 4.56 | -11.42 | 8.45 | 13 | |
P/B Ratio | 0.42 | 0.51 | 0.51 | 0.57 | 0.71 | |
PTB ratio | 0.42 | 0.51 | 0.51 | 0.57 | 0.71 | |
EV to sales | 1.9 | 2 | 2.3 | 2.19 | 2.26 | |
Enterprise value over EBITDA | -50.86 | 313.46 | 26.13 | 33.32 | 27.92 | |
EV to operating cash flow | 28.82 | 14.27 | -212.05 | 18.24 | 24.08 | |
EV to free cash flow | 55.79 | 16.82 | -42.34 | 27.34 | 35.7 | |
Earnings yield | -0.07 | -0.02 | 0.02 | 0.01 | 0.01 | |
Free cash flow yield | 0.08 | 0.22 | -0.09 | 0.12 | 0.08 | |
Debt to equity | 1.47 | 1.47 | 1.47 | 1.4 | 1.38 | |
Debt to assets | 0.41 | 0.42 | 0.4 | 0.4 | 0.39 | |
Net debt to EBITDA | -38.83 | 228.52 | 19.08 | 23.02 | 17.76 | |
Current ratio | 1.18 | 1.21 | 1.17 | 1.19 | 1.19 | |
Interest coverage | -17.75 | 0.5 | 3.06 | 1.45 | 1.55 | |
Income quality | -1.62 | 32.51 | -0.3 | 10.48 | 6.4 | |
Dividend Yield | 0 | 0 | 0.03 | 0 | 0.01 | |
Payout ratio | 0 | 0 | 1.4 | 0 | 0.97 | |
Sales general and administrative to revenue | 0.08 | -0.08 | 0.08 | 0.08 | 0.08 | |
Research and developement to revenue | 0 | 0 | 0.01 | 0.01 | 0.01 | |
Intangibles to total assets | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |
Capex to operating cash flow | -0.48 | -0.15 | 4.01 | -0.33 | -0.33 | |
Capex to revenue | -0.03 | -0.02 | -0.04 | -0.04 | -0.03 | |
Capex to depreciation | -0.84 | -0.44 | -1.03 | -0.98 | -0.74 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 4.4K | 2.51K | 2.71K | 2.04K | 2.38K | |
ROIC | -0.01 | 0 | 0.01 | 0.01 | 0.01 | |
Return on tangible assets | -0.01 | 0 | 0 | 0 | 0 | |
Graham Net | -7.71K | -7.54K | -7.75K | -7.52K | -7.33K | |
Working capital | 69.27B | 71.27B | 67.7B | 73.31B | 72.66B | |
Tangible asset value | 233.23B | 229.52B | 238.17B | 244.9B | 239.99B | |
Net current asset value | -172.46B | -180.97B | -188.15B | -187.77B | -187.85B | |
Invested capital | 1.47 | 1.47 | 1.47 | 1.4 | 1.38 | |
Average receivables | 139.49B | 131.3B | 143.86B | 164.38B | 169.46B | |
Average payables | 121.65B | 121.84B | 131.51B | 141.08B | 135.44B | |
Average inventory | 259.06B | 237.65B | 239.41B | 247.31B | 226.89B | |
Days sales outstanding | 51.9 | 47.97 | 69.36 | 66.78 | 69.04 | |
Days payables outstanding | 50.14 | 49.75 | 70.17 | 61.25 | 60.06 | |
Days of inventory on hand | 100.51 | 94.17 | 123.61 | 106.81 | 96.38 | |
Receivables turnover | 1.73 | 1.88 | 1.3 | 1.35 | 1.3 | |
Payables turnover | 1.79 | 1.81 | 1.28 | 1.47 | 1.5 | |
Inventory turnover | 0.9 | 0.96 | 0.73 | 0.84 | 0.93 | |
ROE | -0.03 | -0.01 | 0.01 | 0.01 | 0.01 | |
Capex per share | -157.29 | -103.52 | -190.54 | -185.34 | -142.89 |
5741.T Frequently Asked Questions
What is UACJ Corporation stock symbol ?
UACJ Corporation is a JP stock and trading under the symbol 5741.T
What is UACJ Corporation stock quote today ?
UACJ Corporation stock price is $4590 today.
Is UACJ Corporation stock public?
Yes, UACJ Corporation is a publicly traded company.